Welcome to LookChem.com Sign In|Join Free
  • or
5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid is a heterocyclic chemical compound with the molecular formula C9H8N4O2. It features a unique structure that includes both nitrogen and oxygen atoms, making it a versatile building block in the synthesis of pharmaceutical drugs.

87253-62-1

Post Buying Request

87253-62-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87253-62-1 Usage

Uses

Used in Pharmaceutical Industry:
5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique structure allows for the development of new and effective medications to treat a wide range of medical conditions.
Used in Research and Development:
5,7-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLIC ACID is also utilized in research and development processes, where it can be further modified or combined with other molecules to create novel drug candidates. Its presence in the scientific community aids in the discovery of new therapeutic agents and contributes to the advancement of pharmaceutical sciences.
Safety Considerations:
Due to its potential hazards, it is crucial to handle 5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid with care and in accordance with proper safety guidelines. This ensures the safety of researchers and the environment while maintaining the integrity of the compound for its intended applications.

Check Digit Verification of cas no

The CAS Registry Mumber 87253-62-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,2,5 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 87253-62:
(7*8)+(6*7)+(5*2)+(4*5)+(3*3)+(2*6)+(1*2)=151
151 % 10 = 1
So 87253-62-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N4O2/c1-4-3-5(2)12-8(9-4)10-6(11-12)7(13)14/h3H,1-2H3,(H,13,14)/p-1

87253-62-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,7-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLIC ACID

1.2 Other means of identification

Product number -
Other names 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87253-62-1 SDS

87253-62-1Relevant academic research and scientific papers

Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase

Patil, Vikas,Kale, Manoj,Raichurkar, Anandkumar,Bhaskar, Brahatheeswaran,Prahlad, Dwarakanath,Balganesh, Meenakshi,Nandan, Santosh,Shahul Hameed

, p. 2222 - 2225 (2014/05/06)

Novel triazolopyrimidine acylsulfonamides class of antimycobacterial agents, which are mycobacterial acetohydroxyacid synthase (AHAS) inhibitors were designed by hybridization of known AHAS inhibitors such as sulfonyl urea and triazolopyrimidine sulfonamides. This Letter describes the synthesis and SAR studies of this class of molecules by variation of two parts of the molecule, the phenyl and triazolopyrimidine rings. SAR study describes optimisation of enzyme potency, whole cell potency and evidence of mechanism of action.

Design and synthesis of novel anthranilic diamides containing 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine

Dong, Wei-Li,Liu, Xing-Hai,Xu, Jun-Ying,Li, Zheng-Ming

experimental part, p. 530 - 533 (2009/04/06)

A new kind of anthranilic diamides containing 5,7-dimethyl[1,2,4] triazolo[1,5-α]pyrimidine were designed and synthesised. Their structures were identified by means of elemental analysis, IR, 1H NMR and MS spectra. As the key intermediate, ethyl 5,7-dimethyl[1,2,4]triazolo[1,5-α] pyrimidine-2-carboxylate (7) was synthesised by applying microwave irradiation.

Dialkyl bicyclic heterocycles with a bridgehead nitrogen as purine analogs possessing significant cardiac inotropic activity

Okabe,Bhooshan,Novinson,et al.

, p. 735 - 751 (2007/10/02)

A number of 5,7-dialkyl-s-triazolo[1,5-a]pyrimidines and 5,7-dialkylpyrazolo[1,5-a]pyrimidines and related heterocycles containing a bridgehead nitrogen have been prepared and studied as cardiovascular agents in the anesthetized dog. A number of these compounds have exhibited significant inotropic activity with little effct on heart rate. Especially active were 5,7-dialkyl-2-amino or 2-alkylthio-2-triazolo[1,5-a]pyrimidines. In contrast, highly polar purine analogs in these ring systems compounds such as 5,7-di-n-propyl-2-benzylthio-1,3,4-thiadiazolo[3,2-a]pyrimidine bromide 45 containing a charge on the bridgehead nitrogen, were inactive. The detailed structure activity relationship of the dialkyl derivatives of related ring systems are discussed. The presence of certain ring nitrogen atoms are vital to potent in vivo activity, presumably due to specific enzyme binding at these sites. Several of the compounds studied, showed oral activity and are excellent candidates for further evaluation in man.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 87253-62-1